ProfileGDS4718 / 238097_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 55% 56% 59% 63% 59% 51% 51% 65% 52% 59% 55% 57% 64% 61% 55% 58% 57% 50% 57% 53% 59% 54% 58% 60% 60% 55% 51% 55% 65% 62% 59% 50% 59% 59% 56% 53% 53% 60% 60% 53% 56% 61% 57% 52% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.7996155
GSM549102patient 115, normal, homogenized [OPG study]5.8621356
GSM549104patient 119, normal, homogenized [OPG study]6.0466759
GSM549108patient 138, normal, homogenized [OPG study]6.3243863
GSM549119patient 077, normal, homogenized [OPG study]6.0688859
GSM549133patient 032, cancer, homogenized [OPG study]5.4998351
GSM549139patient 042, cancer, homogenized [OPG study]5.5730151
GSM549099patient 107, normal, homogenized [OPG study]6.4144965
GSM549109patient 139, normal, homogenized [OPG study]5.6774152
GSM549110patient 046, normal, homogenized [OPG study]6.0873259
GSM549114patient 063, normal, homogenized [OPG study]5.7578255
GSM549122patient 082, normal, homogenized [OPG study]5.9438357
GSM549134patient 033, cancer, homogenized [OPG study]6.3573264
GSM549136patient 036, cancer, homogenized [OPG study]6.1959861
GSM549140patient 044, cancer, homogenized [OPG study]5.7956955
GSM549111patient 047, normal, homogenized [OPG study]5.987158
GSM549113patient 057, normal, homogenized [OPG study]5.8881357
GSM549132patient 031, cancer, homogenized [OPG study]5.4859850
GSM549137patient 038, cancer, homogenized [OPG study]5.9550357
GSM549142patient 047, cancer, homogenized [OPG study]5.8116953
GSM549100patient 110, normal, homogenized [OPG study]6.0546159
GSM549107patient 135, normal, homogenized [OPG study]5.7168954
GSM549115patient 068, normal, homogenized [OPG study]5.9867758
GSM549116patient 072, normal, homogenized [OPG study]6.1110460
GSM549120patient 078, normal, homogenized [OPG study]6.1553560
GSM549131patient 030, cancer, homogenized [OPG study]5.7706555
GSM549118patient 074, normal, homogenized [OPG study]5.5635251
GSM549129patient 027, cancer, homogenized [OPG study]5.8003655
GSM549123patient 088, normal, homogenized [OPG study]6.5024965
GSM549124patient 006, cancer, homogenized [OPG study]6.2430862
GSM549126patient 015, cancer, homogenized [OPG study]6.0240959
GSM549128patient 025, cancer, homogenized [OPG study]5.5361350
GSM549103patient 117, normal, homogenized [OPG study]6.0459859
GSM549117patient 073, normal, homogenized [OPG study]5.9744559
GSM549138patient 041, cancer, homogenized [OPG study]5.8708156
GSM549141patient 045, cancer, homogenized [OPG study]5.6753953
GSM549130patient 028, cancer, homogenized [OPG study]5.6562653
GSM549101patient 111, normal, homogenized [OPG study]6.1837560
GSM549105patient 128, normal, homogenized [OPG study]6.1128760
GSM549106patient 134, normal, homogenized [OPG study]5.6353553
GSM549112patient 048, normal, homogenized [OPG study]5.8662456
GSM549125patient 011, cancer, homogenized [OPG study]6.2206261
GSM549127patient 024, cancer, homogenized [OPG study]5.9459557
GSM549135patient 035, cancer, homogenized [OPG study]5.5889952